Navigation Links
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
Date:7/1/2009

LONDON, July 1 /PRNewswire/ -- Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin(R) (trastuzumab)*, is the winner of the 2009 Dr. Paul Janssen Award for Biomedical Research. An independent committee of world-renowned scientists selected Dr. Ullrich, who on September 8 will receive a $100,000 prize during a ceremony in Beerse, Belgium.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/pauljanssenaward/38987/

"Dr. Ullrich was chosen for his pioneering work in applying molecular biology and molecular cloning to the discovery of protein therapeutics for the treatment of a wide range of diseases, including diabetes and cancer," said Solomon Snyder, M.D., distinguished service professor of Neuroscience, Pharmacology and Psychiatry, Johns Hopkins School of Medicine and chairman of The Dr. Paul Janssen Award Selection Committee.

"He is one of few basic scientists whose work not only has influenced academic research, but also has helped millions of patients suffering from major chronic diseases," Snyder continued. "We received a number of outstanding nominations for this year's Award and are pleased to acknowledge Dr. Ullrich with this distinction. His work has had a remarkable impact on human health and truly embodies the efforts of the Award's namesake, 'Dr. Paul,' who helped save millions of lives through his contribution to the discovery and development of more than 80 medicines."

Ullrich has pioneered the translation of genomics-based discoveries into novel approaches for the treatment of major diseases. Working at Genentech, Inc. in the early 1980s, he developed genetically engin
'/>"/>

SOURCE Johnson & Johnson
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
2. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
3. Video: Data From 185,000 ICU Admissions Show Significant Reductions in Mortality:
4. Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
5. Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech
6. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
7. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
8. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
9. Video: Keppra XR(TM) Approved in the U.S.
10. Video: Fortune 1000 Executives: New President Must Fix Education Gap
11. Video: Moms Raise Red Flag About the Dangers of Widely Undiagnosed Bleeding Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... 14 Array BioPharma Inc. (Nasdaq: ... today announced that they entered into an agreement ... glucokinase activator program, including ARRY-403, currently being tested ... with Type 2 diabetes. ,, Under ... an upfront payment of $60 million and additional ...
(Date:12/14/2009)... JUPITER, Fla., Dec. 14 Dyadic International, ... it has extended its collaboration with The Scripps ... with Scripps to re-annotate the genome of Dyadic,s ... agreement is a continuation of the successful relationship ... 2006 when Dyadic engaged Scripps to annotate the ...
(Date:12/14/2009)... Dec. 14 The third edition of ... , published by the Infusion Nurses ... for anthracycline extravasation.(1) Anthracyclines are a group ... epirubicin that have been used in the treatment ... 1970s.(2) ,, According to the INS ...
(Date:12/14/2009)... Lionbridge (Nasdaq: LIOX ) today announced ... master services agreement with a multi-billion dollar ... serve patients in approximately 100 countries. With ... provider for translation of the company,s online ... resources, legal, and corporate communications information. Lionbridge ...
Breaking Biology Technology:Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3
... - The latest piece of the University of Wisconsin-Milwaukee's ... in place. With the help of two corporate sponsors, the ... arm designed to promote technology transfer. , ,The foundation, which ... received $1 million in seed funding from both Wisconsin ...
... note: This is the second in a three-part series ... of WTN Media's Boardroom Perspectives column, are written by ... Solutions, LLC . , ,Question: What is the ... Some of you may be pondering, Isn't the company's ...
... director of The Morgridge Institute for Research at the ... shaping its direction and values. And the search for ... private, not-for-profit research institute is officially seeking nominations and ... institute's core mission is to bring together scientists from ...
Other Biology Technology:UWM launches research foundation 2Corporate control begins with a strong board 2Corporate control begins with a strong board 3Corporate control begins with a strong board 4
(Date:12/15/2009)... As soon as babies are born, they ... and e-coli. For up to a month, their immune ... infections are often minor, they can lead to serious ... systems, University of Missouri researchers have pinpointed a group ... an immune-strengthening vaccine. , "We,re trying to improve the ...
(Date:12/15/2009)... agreement with the British Society for Research on Ageing ... Biogerontology for an initial period of three ... the Biogerontology editorial board and will acquire ... sponsor the society and provide society members with free ... . , Biogerontology offers a platform for ...
(Date:12/15/2009)... GenWay Clinical Laboratory, San Diego, California, has been ... Pathologists (CAP), based on results of a recent ... was advised of this national recognition and congratulated ... GenWay Biotech Inc. GenWay Clinical Laboratory is one ... CAP Laboratory Accreditation Program, begun in the early ...
Breaking Biology News(10 mins):Researchers work on vaccine to improve immune system in newborns 2Maybe Men Arent So Picky After All 50309 1Maybe Men Arent So Picky After All 50309 2The Healthcare Scoop Community Says 26apos 3BEye Care 26apos 3B 50306 1The Healthcare Scoop Community Says 26apos 3BEye Care 26apos 3B 50306 2The Healthcare Scoop Community Says 26apos 3BEye Care 26apos 3B 50306 3Access Pharmaceuticals Announces Commercial Launch of MuGard 28TM 29 in Greece by SpePharm 50303 1Access Pharmaceuticals Announces Commercial Launch of MuGard 28TM 29 in Greece by SpePharm 50303 2Access Pharmaceuticals Announces Commercial Launch of MuGard 28TM 29 in Greece by SpePharm 50303 3
... Editor : Note that it was published in the ... , A new analysis based on animal studies suggests ... more could have permanent effects on the nervous system. ... considered safe by the Environmental Protection Agency, according to ...
... Science has established a program to assist scientists ... "Our colleagues in science have historically been a ... director of DOE's Office of Science, in a ... colleges, including those in Alabama, Louisiana and Mississippi; ...
... a promising new vaccine against a pre-cancerous cervical virus ... cervical cancer, according to a study presented today during ... in Cancer Prevention Research meeting in Baltimore. ... published in early October, confirmed the vaccine's efficacy from ...
Other Biology News:Does manganese inhaled from the shower represent a public health threat? 2Does manganese inhaled from the shower represent a public health threat? 3DOE's Office of Science sets up program to aid scientists displaced by Hurricane Katrina 2Updated data on novel HPV vaccine confirms efficacy in large population 2
... [APS 26] to Presenilin 2 Alzheimer's ... of the disease carry mutations in the ... precursor protein (APP). These disease-linked mutations result ... of amyloid-beta (main component of amyloid deposits ...
assays for phosphatase, lipase, nucleoside triphosphatases (ATPase, GTPase etc). HTS and follow up studies for phosphatase inhibitors. Quantitation of phosphate content in protein, lipids, and DNA....
One-step, microplate or cuvet, turbidometric, linear detection range 0.096 mg/dL to 11.5 mg/dL. Procedure: 5 min....
... Kb RNA Ladder is suitable for sizing single-stranded RNA ... or formaldehyde agarose gels. The ladder consists of nine ... 4 6 8 and 10 kb) to simplify size ... the other bands allowing easy orientation and identification of ...
Biology Products: